Lipitor or crestor for cholesterol?

What makes Lipitor and Crestor different?

Lipitor (atorvastatin) and Crestor (rosuvastatin) are both statins that lower LDL cholesterol and reduce cardiovascular risk. Lipitor works by blocking HMG-CoA reductase in the liver to cut cholesterol production. Rosuvastatin does the same, but its molecular structure allows stronger binding to the enzyme, giving it more potent LDL reduction at equivalent doses.

How much more effective is Crestor at lowering LDL?

Studies show rosuvastatin 10 mg lowers LDL by 43-46 percent, while atorvastatin 10 mg lowers esh by 35-39 percent. At higher doses, Crestor 40 mg can reach 55-60 percent reduction, compared to Lipitor 80 mg's 47-52 percent. Most patients achieve target LDL levels with 10-20 mg of either drug.

What side effects do patients ask about?

Both drugs share common statin side effects: muscle pain, weakness, and elevated liver enzymes. Patients frequently report these complaints when asking doctors about statin intolerance. Rare but serious risks include rhabdomyolysis and diabetes risk. In clinical trials, rosuvastatin showed slightly higher diabetes incidence than atorvastatin.

Why are companies challenging this patent?

Pfizer's patent on Lipitor expired in 2011, allowing generic atorvastatin to dominate the market. AstraZeneca's Crestor patent expired in 2016. Companies challenged both patents through Paragraph IV filings to launch generic versions early. The challenges led to early generic entry and price drops.

When does exclusivity expire?

No exclusivity remains for either drug. Full generic competition exists for both atorvastatin and rosuvastatin. Generic versions trade at 80-90 percent less than brand-name prices before expiry.

Can biosimilars enter before patent expiry?

Lipitor and Crestor are small-molecule drugs, not biologics. No biosimilars exist for these statins. Generic chemical drugs compete after patent loss, but no biologic rules apply.

Who makes Lipitor and Crestor?

Pfizer originally developed Lipitor and still sells some brand-name versions. AstraZeneca developed Crestor. Generic manufacturers like Teva, Mylan, and Ranbaxy now supply most volumes under their own names.

How does this drug compare with Keytruda?

Lipitor and Crestor are oral daily pills for metabolic disease. Keytruda is an immunotherapy cancer treatment. The two classes share no mechanism,竞争竞争, price structure, or clinical data.